News of Note—Japanese robotics company Riverfield bags $10M; Abbott earns CE mark for next-gen stent

News of note

> Japanese robotics player Riverfield scored 1.15 billion yen ($10.1 million) in new financing to fuel its mission to undercut Intuitive Surgical. Nikkei Asian Review article

> Abbott received a CE mark for its next-generation drug-eluting stent, the Xience Sierra. Improvements include better flexibility, a thinner profile and smaller diameters. Drug Delivery Business News article

> The Chinese FDA approved Allergan’s eye implant for the treatment of macular edema that follows branch retinal vein occlusion or central retinal vein occlusion. Release

Your Daily Newsletter — Free

Enjoying this story? Subscribe to FierceBiotech!

Biopharma is a fast-growing world where big ideas come along every day. Our subscribers rely on FierceBiotech as their must-read source for the latest news, analysis and data in the world of biotech and pharma R&D. To read on the go, sign up today to get biotech news and updates delivered right to your inbox!